ClearFlow | Improve Cardiac Surgery Outcomes

ClearFlow, Inc. is a medical device company based in Bend, Oregon, founded in 2007 by cardiothoracic surgeons Dr. Edward Boyle and Dr. Marc Gillinov. The company focuses on developing innovative technologies to enhance outcomes in cardiac and thoracic surgery, particularly by addressing complications related to retained blood and chest tube occlusion. The flagship product, the PleuraFlow Active Tube Clearance System, is a chest tube designed to prevent thrombus obstructions and maintain drainage after surgery. This FDA-approved device uses a magnetic drive to clear blockages without compromising sterility, significantly reducing the need for surgical re-interventions. ClearFlow also offers the ClearFix Rigid Sternal Fixation system, which stabilizes fractures of the anterior chest wall and promotes recovery. ClearFlow has sold over 11,000 units in North America and Europe and is ISO 13485 certified. The company collaborates with healthcare institutions and key opinion leaders to establish best practices in postoperative care. With a commitment to improving patient recovery and reducing healthcare costs, ClearFlow continues to expand its technology into other surgical specialties.

• Employees 25
• Founded 2007
• Annual Revenue $16000000
• Total Funding $47478843